← Eichor
Condition: Optic Nerve Diseases Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Optic Nerve Diseases

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior Disorder
NA · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06629207Topotecan and Melphalan for Retinoblastoma
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT04799002AnovaOS Network Powered Patient Registry
Phase N/A · 1 location(s) · Anova Enterprises, Inc · NCT05013944Comparison of Diagnostic Performances of 3D FLAIR, DIR and PSIR Sequences in Optic Neuritis
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT06494228OCT Angiography and NRAI in Dementia
Phase N/A · 1 location(s) · Oregon Health and Science University · NCT03761381Neoadjuvant Tebentafusp for Uveal Melanoma
Phase 2 · 2 location(s) · Thomas Jefferson University · NCT06414590Optic Nerve Head Strain in Non-glaucoma Subjects
EARLY_Phase 1 · 1 location(s) · Johns Hopkins University · NCT07425535Effects of Aphasia Identification Cards on Service Workers' Comprehension of People With Aphasia
NA · 1 location(s) · University of Massachusetts, Amherst · NCT06990997Repetitive Transorbital Alternating Current Stimulation for Optic Neuropathies
NA · 1 location(s) · NYU Langone Health · NCT06662448Suture Lid Spring for Lid Closure in Patients With Facial Nerve Palsy
EARLY_Phase 1 · 2 location(s) · University of Alberta · NCT06895902Use of Tinted Contact Lenses for Concussion-Related Light Sensitivity
NA · 1 location(s) · University of Alabama at Birmingham · NCT07223086Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biologica
Phase N/A · 5 location(s) · National Cancer Institute (NCI) · NCT01109394Assessing Biomarker in Giant Cell Arteritis and Polymyalgia Rheumatic
Phase N/A · 1 location(s) · University of Bonn · NCT06460142Neoadjuvant Immunotherapy for Patients With High-risk Eye Melanoma
Phase 1 · 1 location(s) · Inge Marie Svane · NCT07501117Intraoperative OCT Guidance of Intraocular Surgery II
Phase N/A · 1 location(s) · Duke University · NCT03713268Dynamic Light Scattering Ocular Measurement in the Detection of Dementia
Phase N/A · 1 location(s) · MD Stem Cells · NCT06613971China National Registry of Neuro-Inflammatory Diseases
Phase N/A · 1 location(s) · Beijing Tiantan Hospital · NCT05154370Cochlear Implanted Listening Effort and Hearing Attention
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04733950Evaluation of Nystagmus Examination Using Wearable AR Glasses in Vertigo Patients
NA · 1 location(s) · Chang Gung Memorial Hospital · NCT07238387Efficacy and Safety of Intranasal Cenegermin in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy
Phase 3 · 18 location(s) · Dompé Farmaceutici S.p.A · NCT07453888Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune D
Phase 4 · 1 location(s) · Toyos Clinic · NCT06964269Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Phase 1 · 77 location(s) · Chugai Pharmaceutical · NCT06371417Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases
Phase 1/Phase 2 · 1 location(s) · Peking University Third Hospital · NCT06828042Utilisation of Health Services and Quality of Life in Patients With Atypical Parkinsonian Syndromes
Phase N/A · 1 location(s) · University Hospital Southampton NHS Foundation Trust · NCT06645626Clinical Trial Readiness for the Dystroglycanopathies
Phase N/A · 1 location(s) · Katherine Mathews · NCT00313677A Feedback-enabled Magnetic Device for Temporary Management of Blepharoptosis
NA · 2 location(s) · E-DA Hospital · NCT03812016Optical Neuroimaging and Cognition
Phase N/A · 1 location(s) · University of Cambridge · NCT05460143Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases
Phase 1/Phase 2 · 1 location(s) · Tianjin Medical University General Hospital · NCT07022197The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum Disorders
Phase 1 · 1 location(s) · Tongji Hospital · NCT06620809Phenotypic and Genotypic Characterization of Patients With Dysmetabolism in Greenland
NA · 1 location(s) · Steno Diabetes Center Greenland · NCT06264427
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.